3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Kidney Diseases in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K | 1 |
| Iwano, M | 1 |
| Higgins, DF | 1 |
| Yamaguchi, Y | 1 |
| Nakatani, K | 1 |
| Harada, K | 1 |
| Kubo, A | 1 |
| Akai, Y | 1 |
| Rankin, EB | 1 |
| Neilson, EG | 1 |
| Haase, VH | 1 |
| Saito, Y | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Kidney Diseases
| Article | Year |
|---|---|
Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis.
Topics: Aging; Animals; Disease Models, Animal; Enzyme Activators; Epithelial Cells; Female; Fibrosis; Gene | 2008 |